RARE News

RARE DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ZYXIQ INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026 Ready to Announce with Confidence?

RARE INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 Ready to Announce with Confidence?

TCOM INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Trip.com Group (TCOM) Investors of Securities Class Action Deadline on May 11, 2026 Ready to Announce with Confidence?

RARE Shareholder Alert: Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Ultragenyx Pharmaceutical Inc. – RARE

RARE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline